Related Experiment Videos

Elevated International Normalized Ratio associated with long-term azithromycin therapy in a child with cerebral palsy

Christine M Stork1, Jeanna M Marraffa, Kevin Ragosta

  • 1Departments of Emergency Medicine and Medicine, Upstate Medical University, Syracuse, NY.

Insights

Long-term azithromycin use in a child with cerebral palsy led to coagulopathy, indicated by a high International Normalized Ratio (INR). Treatment with phytonadione normalized the INR, resolving the adverse drug event.

Area of Science:

  • Pediatric Medicine
  • Pharmacology
  • Hematology

Background:

  • Cerebral palsy (CP) patients may have unique responses to medications.
  • Chronic antibiotic use is common in certain patient populations.
  • Coagulopathy can arise from various factors, including medication side effects.

Observation:

  • An 11-year-old boy with CP presented with restlessness and hypoxia.
  • Initial evaluation revealed gallstone pancreatitis and elevated liver enzymes.
  • Significant coagulopathy was noted, with an International Normalized Ratio (INR) of 6.54.

Findings:

  • The patient had a history of chronic prophylactic azithromycin use for anti-inflammatory therapy.
  • Azithromycin was discontinued, and phytonadione was administered.
  • The elevated INR normalized rapidly after phytonadione treatment, indicating a probable drug-related adverse event.

Implications:

  • This case highlights a potential link between long-term azithromycin use and acquired coagulopathy in pediatric patients.
  • Clinicians should monitor coagulation parameters in children with CP on chronic antibiotic therapy.
  • Further research is warranted to explore the mechanism of azithromycin-induced coagulopathy and its prevalence.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...